My first scientific hero was Arrowsmiththe main character in the 1925 novel of the same name by Sinclair Lewis, which almost every medical student of my generation read. It is about an idealistic young man who starts out as a family physician but is not satisfied and wants to be a medical scientist who cures diseases. I identified with him because I grew up in rural Pennsylvania wanting to be a doctor but I was not very sophisticated. When I went to medical school at Harvard in Boston, Massachusetts, I had never seen the inside of a research laboratory, so I immediately took up with classmates who had undergraduate research experience and I credit them with my decision to try research.
What has been the most exciting stage of your career?
I had a great time working on polio in my early years in the lab. But I switched to retroviruses just before the discovery of reverse tran scriptase, which was essential to the biotech nology revolution. We found ourselves at the cutting edge of an absolutely new field in which things were moving extremely rapidly. Every young scientist's objective should be to start something new because that's when things are really fun. If I were beginning my scien tific career today I would study neuroscience, which has fascinated me ever since I encoun tered it during my first year at Harvard Medical School and which still has thrilling frontiers. For the first time, this year's Lindau meeting boasts more female young researchers than male. How can more women be encouraged to take scientific posts?
Has working in the San
When I first started work in the 1970s at the Institut Pasteur in Paris, France, there were no more than five female professors; today, the same institution has close to 50% female professors, which is wonder ful. One way forward is to better recognize the work of women, although I think that this is already progressing. Another issue is children. I made the choice not to have children because I thought it was too dif ficult at that time to have a career and a family -although it might not be the best solution and many other women scientists do choose to have a family. Certainly we can better organize research institutions to offer childcare, for instance. While we all can agree that equity is a good thing, women shouldn't be selected just because they are women. ■ 
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(UCSF), which at the time was of no conse quence whatsoever. That did not bother me in the least because I was working on a very humble problem and having a wonderful time. There was an atmosphere that made it okay to explore any research direction. It was also a lively political environment. I flirted with the Peace and Freedom Party for a while, and it was the time of the Free Speech move ment. There was an open spirit that I had never quite encountered before.
In more than 40 years of cancer research, what hits have we scored?
Two success stories are slam dunks. First, recognition of the fundamental role of the genome in cancer has completely transformed the way we think about every aspect of cancer. Consider the issue of what causes can cer. I view this as the most challenging unsolved problem in cancer research. Genome science may help solve this problem, because the nature of the damage in tumour DNA often represents the chemical signature of the causative agent. This is clearly seen in skin cancers caused by exposure to sunlight, and there are genomic clues for other cancers, such as breast cancer. Or consider early detection of cancer. It seems only a matter of time before either molecular cytology on excretions or circulating DNA help us to detect stealth tumours, such as pan creatic and ovarian cancer. And of course, the implications for therapy are profound.
The second big hit has been in public health -specifically, the substantial drop in lung cancer in the United States that is attributable to the dramatic decline in smoking. Unfor tunately, we are not doing as well in some other realms, such as obesity, or immuniza tion against the papillomavirus, which causes cervical cancer.
Will we find a cure for cancer?
It seems unlikely to me that there will ever be a single cure for cancer. The disease is just too heterogeneous for that. Instead, I would like to emphasize that if we are ever going to con quer this disease, it will be by prevention. For example, we can prevent numerous diseases by vaccination against their causes. Examples include polio, measles, hepatitis B and cervical cancer. We need to know the causes of cancer in order to prevent the disease. The fact that we have not eradicated lung cancer caused by smoking and that we have allowed the tobacco industry to continue to control the agenda is a public disgrace -but the United States has blazed the path and in California we are doing better on this front than most other places.
Has a career spent working on cancer made you more or less fearful of the disease?
Some things haven't changed. My wife has colon cancer and the lead drug for that dis ease is the same one I was prescribing when I was a young physician 50 years ago, which is pretty sobering. So yes, it is a fearsome disease; even with therapy you may never have a truly comfortable day in your life again. By combin ing our eventual understanding about every lesion in the cancer genome with the emerging prospects of immunotherapy, though, I think the future is pretty bright. The most important thing is that being awarded the Nobel prize has not changed the way I feel about myself. It also has not changed the way my colleagues think of me, and has not affected my bank account very much either! I do not see it as a burden, as some people have described it, because I do not take it too seriously. However, it was defi nitely an asset while I was chancellor at UCSF because, rightly or wrongly, it said something to the general community about the quality of the institution. Of course, it has also made it possible to come to a place like Lindau, which is a plus (except for the jetlag 
